A variety of circulating signals provide essential information to the central nervous system (CNS) regarding nutritional status. The gastrointestinal system produces many such molecules that are now known to have profound effects on feeding behavior and the control of metabolism as a consequence of their ability to regulate the neural circuitry involved in metabolic homeostasis. Although many of these substances have been suggested to directly access such brain centers, their lipophobic characteristics suggest that alternative mechanisms should be considered. In this paper, we consider one such alternative, namely, that a specialized group of CNS structures collectively known as the sensory circumventricular organs (CVOs), which are not protected by the normal blood-brain barrier, may play important roles in such blood to brain communications. Specifically, we review a developing literature that shows receptors for, and functional actions of, gastrointestinal hormones such as amylin, cholecystokinin, ghrelin and peptide YY in the area postrema and subfornical organ. Collectively, these observations suggest potentially significant roles for the sensory CVOs in the regulation of energy balance.
Introduction
There is now extensive evidence showing that a variety of circulating signaling molecules provide essential afferent information to the central nervous system (CNS) regarding nutritional status. The gastrointestinal system produces a number of these signaling molecules, which have over the past 10 years been shown to have profound effects on feeding behavior and the control of metabolism as a consequence of their ability to influence activity in the hypothalamic and medullary autonomic control centers involved in metabolic homeostasis. 1, 2 Intriguingly, many of these signaling molecules are peptides, and as a consequence of their lipophobic/hydrophilic nature, they would not be expected to readily cross the normal blood-brain barrier (BBB). Understanding the mechanisms through which these circulating peptides influence the activity of single neurons protected by the BBB is clearly critical to a complete appreciation of the regulatory circuitry controlling the integration of feeding and metabolism.
Access of circulating peptides to the CNS
The original simple explanation describing how circulating signals influenced CNS sites involved in the regulation of food intake was that these molecules readily diffused across the BBB and directly accessed CNS tissue in the hypothalamic and medullary autonomic control centers. In reality, this mechanism is extremely unlikely. The majority of these peptides are lipophobic and therefore their chemistry prohibits them from crossing a normal BBB. A second possibility, which has been explored extensively, is that some of these molecules may be transported from one side of the BBB to the other (for review, see Kastin et al. 3 ). Several mechanisms have been proposed whereby such transport might occur. First, the luminal surface of cerebral vascular endothelial cells integrates and transmits peptidergic information to the CNS side through the production of substances such as nitric oxide, which readily diffuse into the surrounding microenvironment. 4, 5 A second mechanism for transport, which has been the subject of considerable research, is the fact that specific transporters exist for a number of these signaling molecules and have been shown to facilitate transport of these signaling molecules either from blood to brain or from brain to blood. 3, 6 Perhaps the best understood of such transporter systems is the one that has been described for leptin. The location of this transporter in the arcuate nucleus of the hypothalamus (ARC) suggests a potential transport of this molecule from the bloodstream into this important CNS feeding center. 7 A third possibility has been suggested that some areas involved in metabolic control have a modified or 'leaky' BBB. The paraventricular nucleus, ventromedial and lateral hypothalamus are omitted from this discussion as these regions have definitively been shown to exist behind the normal BBB. The ARC, however, is an interesting case. Studies have suggested that a portion of the ARC vasculature is in fact modified and leaky such that substances can readily diffuse in and access the ARC neurons. 8 The ARC has in a number of cases been referred to and adopted as an additional circumventricular organ (CVO) despite the fact that there is no anatomical evidence to date, which suggests that the ARC lacks the normal BBB. [9] [10] [11] Interestingly, the initial studies that showed horseradish peroxidase (HRP) access into the ARC were designed to identify regions of the brain that lack the normal BBB. These studies showed that, following systemic HRP, the primary areas labeled by this molecule were the traditional CVOs. 12 Broadwell and Brightman 12 also reported that 8 h after infusion of HRP, other regions of the brain showed HRP labeling, including the ARC. They concluded that this labeling of HRP in the ARC was a direct result of retrograde axonal transport to ARC neurons that project to the median eminence. Recent studies using more sensitive fluorescence tracers confirm this conclusion. 13, 14 Following systemic administration of hydroxystilbamidine (a fluorogold equivalent), only ARC astrocytes show labeling, an observation that was interpreted to suggest that these glial cells may send processes to vascular endothelial cells. Collectively, these observations do not provide any definitive evidence at this time that ARC neurons are in a preferential position to directly access circulating substances. The final mechanism through which circulating signal peptides may confer their information to the CNS is through actions at specialized regions of the brain that lack the normal BBB collectively known as the circumventricular organs. These regions are unique in that capillaries supplying them have normal fenestrations (unlike the tight junctions observed in regions protected by the BBB) and an anatomically distinct dense vasculature. 15, 16 The CVOs also have dense aggregations of a variety of different peptidergic receptors. [17] [18] [19] [20] [21] [22] In the remainder of this paper, we will highlight recent evidence examining a number of different satiety signals and their effects on central metabolic control as a result of potential direct actions on neurons within two of these CVOs; the subfornical organ (SFO) and the area postrema (AP).
The circumventricular organs
The SFO was first recognized as an important CNS structure at the blood-brain interface in the mid-1980s when it was shown to be the CNS site at which circulating angiotensin acted to influence drinking, vasopressin, oxytocin and ACTH secretion as well as centrally mediated increases in arterial blood pressure. [23] [24] [25] [26] [27] Since then, a number of anatomical and functional studies have shown that the SFO expresses a number of receptors for peptides known to control metabolic status, including amylin, ghrelin and peptide YY (PYY) (Figure 1 ). Thus, the possibility exists that circulating ligands for these receptors would directly access SFO neurons and, through known efferent projections of SFO to hypothalamic autonomic control centers, 28, 29 transmit important signals to these regions. Similarly, the AP, located on the dorsal surface of the medulla is a second CVO (with fenestrated capillaries and thus direct access to the peripheral circulation) that was initially recognized as the chemoreceptor trigger zone involved in controlling the emetic reflex. 30 Since that initial discovery, many studies have shown important roles for the AP in baroreflex regulation controlled by circulating concentrations of vasopressin 31, 32 and angiotensin II. 33, 34 With regard to the control of metabolic function, receptors for amylin, calcitonin gene-related peptide, cholecystokinin, ghrelin, orexin, PYY and vasoactive intestinal polypeptide have all been identified in the AP (Figure 1 ). Thus, AP neurons have the potential to monitor circulating concentrations of these substances and in turn transmit these signals to important autonomic control centers in the medulla. 35, 36 This suggestion of important sensory roles for the CVOs in the control of energy balance has been examined by lesion studies that have determined the effect of destruction of the SFO or AP on body weight and food intake. Many studies examining the effect of AP lesions on body weight have shown clear decreases that are often maintained for weeks following such lesions (in which AP has been lesioned have provided somewhat contentious data, with some showing clear decreases in body weight following such lesions). [37] [38] [39] The effects of SFO lesions on food intake and body weight have not been extensively examined, although the predominant evidence suggests no profound effects of such lesions on these parameters. We have recently undertaken studies in which we have systematically lesioned SFO, AP or both CVOs concurrently, and although no clear effects of either single AP or SFO lesions on body weight and food intake have been shown, we have observed a reduction in body weight and food intake in animals in which both of these CVOs are lesioned (ED Baraboï et al., unpublished observations). Future studies will need to address, more specifically, the potential roles of these structures, especially in physiological situations in which food availability is modified in a variety of experimental ways.
Cholecystokinin and glucagon-like peptide-1 actions at CVOs
Thus, although there has been no systematic investigation of the roles played by the SFO and AP in the integrated control of energy metabolism in food intake, there is now an emerging body of evidence from single-cell recording studies that shows that single neurons in both the SFO and the AP sense low concentrations of a number of important satiety signals. In the remainder of this paper, the evidence in support of the roles of a number of these satiety signals will be examined in more detail. Perhaps one of the first satiety signals shown to have important roles in controlling the activity of AP neurons was cholecystokinin, which was shown to have excitatory effects on AP neurons at low nanomolar concentrations, 40 whereas a more recent study by
Yamamoto et al. 41 has also suggested roles for systemic glucagon-like peptide-1 in the activation of catecholaminergic AP neurons.
Amylin and ghrelin
Another circulating signal that has been shown to induce cFos in AP is the 37-amino-acid peptide amylin, 42 which is secreted from pancreatic b-cells. Extracellular recordings from both the SFO 43 and AP 44 showed that amylin caused concentration-related increases in the activity of neurons in both of these CVOs. Interestingly, in the AP, at least a proportion of the neurons responsive to amylin were also glucose responsive. 44 We have recently used dissociated cell techniques combined with patch-clamp recording to examine, at the singlecell level, the mechanisms through which amylin influences the excitability of SFO neurons. 21 Our studies confirm the earlier study of Reidiger et al. 43 demonstrating clear depolarizing effects of amylin on SFO neurons, which were concentration dependent with a minimal effective concentration of 10 pM (Figure 2) . Use of the whole-cell patch-clamp technique also permits the evaluation of ion channels potentially modulated by satiety signals and, in the case of amylin, we have obtained data suggesting that at least a component of amylin's effects on SFO neurons is the result of the inhibition of a potassium conductance. 21 Ghrelin is another important satiety signal that has recently been shown to have potent appetite-stimulating effects. Ghrelin release from the gut is tightly correlated with meal initiation. 45 Following the demonstration of CNS actions of ghrelin, 46 we examined whether the SFO and AP may also be structures of the brain with the potential to sense circulating ghrelin. In these studies, we first established the presence of mRNA for the growth hormone secretagogue receptor (ghrelin's endogenous receptor) in the SFO using molecular techniques. 21 We then examined the effects of bath administration of ghrelin on dissociated SFO neurons and were able to show that ghrelin had excitatory effects on SFO neurons with a minimal effective concentration of 1 nM. These effects of ghrelin on SFO neurons appear to be mediated by the activation of a non-selective cationic conductance (that is, a different channel target to that observed for amylin). 21 Interestingly, however, our data for amylin and ghrelin in the SFO showed similar depolarizing effects of two satiety signals that exert opposite effects on food intake. We therefore conducted additional experiments to examine whether amylin and ghrelin influence similar or different populations of SFO neurons by testing each neuron with both signaling molecules. These studies showed conclusively that in the SFO there are two different subpopulations of neurons, one responsive to amylin and not ghrelin and the second responsive to ghrelin but not amylin. In no circumstances in these studies did we record from cells that responded to both of these satiety signals.
A d i p o n e c t i n A m y l i n A n g i o t e n s i n C C K
As indicated earlier, our focus on ghrelin effects in CVOs had led us to examine the effect of ghrelin on AP neurons, and the study by Zigman et al., 22 in addition to our own PCR study, showed growth hormone secretagogue receptor expression in the AP. We also now have preliminary data from recordings of dissociated AP neurons showing that these cells also appear responsive to ghrelin administration (WM Fry and AV Ferguson, unpublished observations). Interestingly, in the AP, however, we have identified two separate sub-populations of AP neurons, one of which responds by depolarization and the second with hyperpolarization in response to ghrelin administration. Future studies will attempt to identify output projections of these two separate sub-populations of ghrelin neurons.
Peptide YY
Another important signaling molecule that has received considerable attention in the literature, in view of its potential to inhibit food intake, 47 is PYY. An established literature has shown the existence of Y1, Y2 and Y5 receptors in the AP, 48 and we have recently begun studies examining the effects of PYY on the excitability of AP neurons. These studies have shown that PYY 1À36 has depolarizing effects on AP neurons as well as an inverse dose relationship with maximal effects at 100 pM but reduced effects of 10 and 1 nM (J Jun and AV Ferguson, unpublished observations). Our preliminary data suggest that these effects are blocked by Y1 antagonists. In contrast, PYY 3À36 hyperpolarizes the majority of the AP neurons we have tested, at higher concentrations than PYY 1À36 (that is, with active concentrations at 1 nM) ( Figure 3 ). These effects of PYY 3À36 appear to be blocked by Y2 antagonists. These data in AP therefore suggest differential effects of PYY 1À36 and PYY 3À36 mediated through different Y receptors on AP neurons. Again, we do not know the output pathways of these two sub-populations of AP neurons and we do not have definitive evidence whether these are separate sub-populations of neurons influenced by the forms of PYY. These studies examining the effects of PYY in AP led us to examine the expression of Y receptors in the SFO, and we have recently undertaken preliminary experiments in which we have also been able to see the effects of PYY 1À36 , which we believe to be mediated by Y1 receptors, in depolarizing the membrane potential of SFO neurons (B Mellado and AV Ferguson, unpublished observations).
Adipokines
A discussion of the roles of satiety signals at the CVOs would not be complete without at least some mention of the potential for adipokines such as leptin and adiponectin to influence the excitability of AP and SFO neurons. We have recently reported that adiponectin influences the activity of
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Ghrelin Amylin AP neurons, again with separate sub-populations of these cells being depolarized and hyperpolarized. 21 Interestingly, microinjection of adiponectin into AP caused small, yet repeatable, changes in arterial blood pressure. We have also shown using single-cell reverse transcription PCR that adiponectin-sensitive AP neurons express mRNA for both adiponectin receptor 1 and receptor 2, supporting the conclusion that expression of both receptors is essential for this adipokine to influence AP neurons. 21 We are also currently investigating the role of adiponectin in SFO, in which we have again shown extensive expression of both receptors and obtained preliminary data showing the effects of this adipokine on SFO neurons (I Alim and AV Ferguson, unpublished observations). Finally, leptin receptors have also been recently reported in the AP and SFO, 49 and we have recently confirmed these data by showing mRNA expression of leptin receptors in the SFO. In our laboratory, we have begun to examine leptin actions in SFO with single-cell recordings, which have shown that a significant proportion of the neurons show changes in membrane potential in response to this adipokine (PM Smith and AV Ferguson, unpublished observations). Although these studies are far from complete, these data again emphasize the potential roles of the CVOs to sense and respond to changes in circulating concentrations of these important adipokines.
Conclusions
In conclusion, we believe that there is now an emerging body of evidence in support of the potential roles for the CVOs as important CNS sensors of circulating signals. These CVOs are unique CNS structures in that they are the only regions of the brain that directly interface with circulating substances that do not cross the normal BBB. CVOs are also unique in that their efferent projections effectively connect with all major hypothalamic (SFO) and medullary (AP) autonomic control centers. In this paper, we have reviewed the evidence suggesting that many circulating satiety signals have the ability to influence the excitability of neurons in these two CVOs. We would thus suggest that these data support important roles for the SFO and AP, unique CNS sensory processing centers, as peripheral information integrators regarding metabolic status.
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